Opinion: Pfizer's Dividend Riskier Than It Looks, Even with a 7% Yield
Pfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
Determine whether a 6-month or 12-month fund is right for you by assessing income stability, essential expenses, and personal risk appetite.
15,911 articlesPfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
A leading mega-cap health stock dropped last year but started the year with a powerful rebound. This guide breaks dow...
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Stellantis faces a pivotal push to revive overseas markets and lift investor confidence. This deep-dive explores the ...
America’s bone health quietly faces a looming $19 billion cost as aging Americans confront fragile bones and rising f...
Jet fuel costs have dropped, yet airfares stay high as demand, hedges, and fees keep tickets elevated. Travelers face...
A troubling local case shows how a fake voter guide can blend into the political scene and affect your finances. Lear...
A high-profile wedding draws attention—and wallets. This feature explores what Kylie Kelce calls Taylor Swift’s weddi...
A $28 billion AI hardware IPO is trading at about 7x forward earnings, sparking a heated debate: is it a disrupted, d...
In a striking move, trump’s crypto disclosure exposes how policy signals and private crypto stakes collide at the hig...
Celebrity endorsements can lift a brand and a wallet—if you know the risks. This article breaks down what brooklyn be...
Bitcoin steadied near the $60,000 level as tensions in the Strait of Hormuz pushed oil higher and equity futures retr...